rs397507537
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_002834.5(PTPN11):c.1402A>C(p.Thr468Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T468M) has been classified as Pathogenic.
Frequency
Consequence
NM_002834.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPN11 | NM_002834.5 | c.1402A>C | p.Thr468Pro | missense_variant | Exon 12 of 16 | ENST00000351677.7 | NP_002825.3 | |
PTPN11 | NM_001330437.2 | c.1414A>C | p.Thr472Pro | missense_variant | Exon 12 of 16 | NP_001317366.1 | ||
PTPN11 | NM_001374625.1 | c.1399A>C | p.Thr467Pro | missense_variant | Exon 12 of 16 | NP_001361554.1 | ||
PTPN11 | XM_011538613.3 | c.1411A>C | p.Thr471Pro | missense_variant | Exon 12 of 16 | XP_011536915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTPN11 | ENST00000351677.7 | c.1402A>C | p.Thr468Pro | missense_variant | Exon 12 of 16 | 1 | NM_002834.5 | ENSP00000340944.3 | ||
PTPN11 | ENST00000635625.1 | c.1414A>C | p.Thr472Pro | missense_variant | Exon 12 of 15 | 5 | ENSP00000489597.1 | |||
PTPN11 | ENST00000635652.1 | c.415A>C | p.Thr139Pro | missense_variant | Exon 4 of 5 | 3 | ENSP00000489541.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Noonan syndrome with multiple lentigines Pathogenic:1
Variant summary: PTPN11 c.1402A>C (p.Thr468Pro) results in a non-conservative amino acid change located in the Tyrosine-specific protein phosphatase, PTPase domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251186 control chromosomes. c.1402A>C has been reported in the literature in individuals affected with Leopard Syndrome (e.g. Limongelli_2007, Seishima_2007). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and showed that this variant increased melanin synthesis (Motegi_2015). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate that the variant may enhance melanin synthesis (PMID: 25917897); Not observed at significant frequency in large population cohorts (gnomAD); Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24803665, 30417923, 29493581, 38366647, 38540404, 25917897, 17927788) -
Cardiovascular phenotype Pathogenic:1
The p.T468P pathogenic mutation (also known as c.1402A>C), located in coding exon 12 of the PTPN11 gene, results from an A to C substitution at nucleotide position 1402. The threonine at codon 468 is replaced by proline, an amino acid with highly similar properties. This mutation has been identified in individuals with Noonan syndrome with multiple lentigines, including a de novo occurrence (Seishima M, et al. Br. J. Dermatol. 2007 Dec; 157(6):1297-9; Motegi S, et al. Acta Derm. Venereol. 2015 Nov; 95(8):978-84). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the supporting evidence, this variant is expected to be causative of PTPN11-related RASopathy; however, its clinical significance for metachondromatosis is unclear. -
RASopathy Pathogenic:1
This variant disrupts the p.Thr468 amino acid residue in PTPN11. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12058348, 16377799, 18372317). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 468 of the PTPN11 protein (p.Thr468Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Noonan Syndrome with Multiple Lentigines (NSML) (also known as LEOPARD syndrome) (PMID: 17927788, 25917897). ClinVar contains an entry for this variant (Variation ID: 40547). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PTPN11 protein function. Experimental studies have shown that this missense change affects PTPN11 function (PMID: 25917897). For these reasons, this variant has been classified as Pathogenic. -
Noonan syndrome and Noonan-related syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at